首页|血清FGF19及FGF21在不同孕前体质量指数妊娠期糖尿病患者中的表达及与胰岛素抵抗的相关性

血清FGF19及FGF21在不同孕前体质量指数妊娠期糖尿病患者中的表达及与胰岛素抵抗的相关性

扫码查看
目的:探讨不同孕前体质量指数妊娠期糖尿病患者的血清成纤维细胞生长因子19(FGF19)及成纤维细胞生长因子21(FGF21)的表达水平及与胰岛素抵抗的相关性.方法:选取2019 年6 月—2022 年6 月某院行口服葡萄糖耐量试验(OGTT)的孕妇120 例为研究对象,根据OGTT结果分为正常对照组(NGT组,45 例)和妊娠期糖尿病组(GDM组,75 例),依据孕前体质量指数(BMI)将GDM组患者进一步分为正常体重组(GDM1 组,37 例,孕前BMI<24 Kg/m2)和超重/肥胖组(GDM2 组,38例,孕前BMI≥24 Kg/m2).根据空腹血糖(FPG)和胰岛素水平(INS)计算稳态型胰岛素抵抗指数(HOMA-IR)及胰岛β细胞功能指数(HOMA-β),比较3 组糖、脂代谢指标[甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白-胆固醇(LDL-C)及高密度脂蛋白-胆固醇(HDL-C)]、FGF19、FGF21 水平,线性相关和线性回归分析FGF19、FGF21 浓度与各指标的关联性,Logistic回归分析影响妊娠期糖尿病发病的因素.结果:3 组间孕前BMI、空腹血糖(FPG)、空腹胰岛素(FINS)、HOMA-IR、HOMA-β、TG、FGF19、FGF21 比较,差异有统计学意义(P<0.05).相关性分析结果显示,FGF19 与孕前BMI、FPG、FINS、HOMA-IR、FGF-21 呈负相关,FGF-21 与孕前BMI、FINS、HOMA-IR、TC、TG、HDL-C呈正相关.线性回归分析结果示,孕前BMI、FPG、FGF21 水平影响孕妇FGF19 表达,孕前BMI水平也影响孕妇FGF21 表达.多因素Logistic回归方程分析结果显示,孕前BMI、FGF19、FGF21、TG为影响GDM发病的因素.结论:不同孕前 BMI的妊娠期糖尿病患者血清中 FGF19 及 FGF21 水平不同,孕前 BMI为影响FGF19 及FGF21 表达的因素,也是影响GDM发病的因素.
Expression of serum FGF19 and FGF21 in gestational diabetes patients with different pre-pregnancy body mass index and their correlation with insulin resistance
Objective:To investigate the correlation between serum levels of fibroblast growth factor 19(FGF19)and fibroblast growth factor 21(FGF21)and insulin resistance in pregnant women with different pre-pregnant body mass index.Methods:A total of 120 pregnant women who underwent oral glucose tolerance test(OGTT)in a hospital from June 2019 to June 2022 were selected as the study objects.Based on the results of oral glucose tolerance test,they were divided into a NGT group(45 cases,OGTT results negative for pregnant women as normal control group)and a GDM group(75 cases,gestational diabetes mellitus).According to pre-pregnancy body mass index(pre-pregnancy BMI),The GDM group was re-divided into a normal weight group(GDM1 group,37 cases,pre-pregnancy BMI<24Kg/m2)and a super-recombination group(GDM2 group,38 cases,pre-pregnancy BMI≥24 Kg/m2).General clinical biochemical indexes were determined such as TG,TC,LDL-C,HDL-C,FGF19 and FGF21.SPSS 26.0 software was used for statistical analysis of the data.Results:The results of variance analysis or rank sum test showed no statistical significance in age,gesta-tional age,HOMA-β,TC and LDL-C levels among the three groups(P>0.05),while statistically significant differences were mani-fested in pre-pregnancy BMI,FPG,FINS,HOMA-IR,TG and HDL-C(P<0.05).SerumFGF19 levels were statistically different a-mong the 3 groups,with GDM2 group<GDM1 group<NGT group[(11.32±4.61)<(15.55±2.87)<(21.87±2.98),P<0.05].Serum FGF21 level in GDM2 group was higher than that in NGT group and GDM1 group.Serum FGF21 level in GDM1 group was not significantly different from that in NGT group[(40.62±3.12)VS(29.55±3.26)/(27.60±2.35),P<0.05].The corre-lation analysis showed that the FGF19 level in GDM group was negatively correlated with HOMA-IR and the pre-pregnancy BMI(r=-0.353,-0.484,P<0.05),while FGF21 level was positively correlated with HOMA-IR and the pre-pregnancy BMI(r=0.251,0.418,P<0.05).The results of multivariate regression analysis showed that pre-pregnancy BMI was the main influencing factor of FGF19 and FGF21,and FPG was also the influencing factor of FGF19.FGF19 and FGF21 were mutually influencing factors.Multivari-ate Logistic regression model showed that pre-pregnancy BMI and FGF19 had statistically significant effects on GDM.Conclusion:The levels of FGF19 and FGF21 in the serum of gestational diabetes patients with different pre-pregnancy body mass index were different,which were correlated with insulin resistance.FGF19 and FGF21 may delay the progression of GDM.

Diabetes mellitus,gestationalFibroblast growth factor 19Fibroblast growth factor 21Insulin resistanceBMI

薛丽、赵文娣、吴晨辰、张晓梅、孙卫华

展开 >

蚌埠医科大学第一附属医院内分泌科,安徽蚌埠 233000

糖尿病,妊娠 成纤维细胞生长因子19 成纤维细胞生长因子21 胰岛素抵抗 BMI

安徽省卫生健康科研项目

AHWI20226056

2024

淮海医药
蚌埠市医学科学情报站 《淮海医药》编辑部

淮海医药

影响因子:0.58
ISSN:1008-7044
年,卷(期):2024.42(3)
  • 11